BioUtah News
-
2022 BIO Report Ranks Utah in the Top Eight States for Bioscience Specialization
The 2022 TEConomy/BIO report, The US Bioscience Industry: Fostering Innovation and Driving America’s Economy Forward, examines the bioscience industry’s…
-
Participate in Life Sciences Day on the Hill
The annual Life Sciences Day on the Hill provides our industry with the opportunity to get face time…
-
Stryker launches state-of-the-art Neurovascular R&D lab with advanced technology to accelerate stroke care innovation
Stryker, one of the world’s leading medical technology companies, recently opened its Neurovascular (NV) lab, a state-of-the-art lab…
-
Merrimack provides Ipsen report that Onivyde® regimen demonstrated statistically significant improvement in overall survival in previously untreated metastatic pancreatic ductal adenocarcinoma
Cambridge, MA, November 9, 2022 /Business Wire/ – Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] announced…
-
Utah Life Sciences Companies participate in Utah Trade Delegation to Medica 2022
Exhibiting their innovative products and services to over 80,000 visitors, 11 life science companies represented Utah at the MEDICA…
-
Halia Therapeutics Presents at 4th Inflammasome Therapeutics Summit
SALT LAKE CITY–(BUSINESS WIRE)–Halia Therapeutics, a clinical stage biopharmaceutical company advancing innovative medicines to treat diseases driven by…
-
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023
LONDON and SALT LAKE CITY, Nov. 30, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an…
-
Ortho Development Launches Enabling Technology for Total Knee
by Julie A. Vetalice Ortho Development BKS Total PSI has been released for commercial distribution in the United…
-
Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654 at the 64th ASH Annual Meeting & Exposition
Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654
-
NEW DIGITAL HEALTH INITIATIVE TO CREATE NEXT GENERATION OF MEDICAL APPS, GAMES, AND TECHNOLOGIES
The University of Utah Health has launched NEW DIGITAL HEALTH INITIATIVE
-
Teva Announces Appointment of Richard Francis as President and CEO
Kåre Schultz to Retire After a Transformative Five-Year Tenure Setting the Stage for an Exciting Future
-
Myriad Genetics Announces UroSuite™, an Industry-First Suite of Genetic Tests for Prostate Cancer, Giving Urologists Access to Timely, Data-driven Medical Information
SALT LAKE CITY, Nov. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
